Evaxion A (EVAX) Operating Income (2020 - 2026)
Evaxion A posted quarterly Operating Income of -$3.8 million for Q1 2026, up 1.27% year-on-year from -$3.8 million in Q1 2025, and up 5.75% on a QoQ basis from -$4.1 million in Q4 2025.
Evaxion A (EVAX) has 7 years of Operating Income data on file, last reported at -$3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 1.27% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$9.2 million (up 35.31% YoY), and the FY2025 full-year result was -$9.2 million, up 37.32% from the prior year.
- Operating Income for Q1 2026 stood at -$3.8 million, up from -$4.1 million in the prior quarter.
- Across five years, Operating Income topped out at $3.0 million in Q3 2025 and bottomed at -$6.5 million in Q4 2022.
- The 5-year median for Operating Income is -$4.4 million (2024), against an average of -$4.4 million.
- The widest annual swing landed in 2022, when Operating Income decreased 23.65%; it then surged 274.58% in 2025.
- A 5-year view of Operating Income shows it stood at -$6.5 million in 2022, then jumped by 33.12% to -$4.4 million in 2023, then grew by 7.79% to -$4.0 million in 2024, then dropped by 0.7% to -$4.1 million in 2025, then climbed by 5.75% to -$3.8 million in 2026.
- The last three Operating Income figures came in at -$3.8 million (Q1 2026), -$4.1 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -445.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.53 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.26 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -7.72 Mn |
| Sep 30, 2021 | -5.91 Mn |
| Jun 30, 2021 | -7.03 Mn |
| Mar 31, 2021 | -5.18 Mn |
| Dec 31, 2020 | -4.65 Mn |
| Sep 30, 2020 | -4.69 Mn |
| Jun 30, 2020 | -3.94 Mn |
| Mar 31, 2020 | -3.29 Mn |